These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 6127169
1. Assessment of renal function during high-dose cis-platinum therapy in patients with ovarian carcinoma. Buamah PK, Howell A, Whitby H, Harpur ES, Gescher A. Cancer Chemother Pharmacol; 1982; 8(3):281-4. PubMed ID: 6127169 [Abstract] [Full Text] [Related]
7. Clinical significance of urinary N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase. Hsu WS, Kao JT, Chen JS. Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):407-9. PubMed ID: 2571671 [Abstract] [Full Text] [Related]
8. [Determination of urinary N-acetyl-beta-D-glucosaminidase (NAG) excretion as a parameter of nephrotoxicity due to cis-platin and the effect of fosfomycin (FOM) on its nephrotoxicity]. Matsuoka R, Inoue T, Miyamura K, Mizutani K, Koike S, Mori H, Kigawa T. Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov; 38(11):2037-44. PubMed ID: 3794453 [Abstract] [Full Text] [Related]
16. Urinary endothelin-1-like immunoreactivity in young male patients with testicular cancer treated by cis-platinum: comparison with other urinary parameters. Takeda M, Komeyama T, Tsutsui T, Mizusawa T, Go H, Hatano A, Tanikawa T. Clin Sci (Lond); 1994 Jun; 86(6):703-7. PubMed ID: 7520380 [Abstract] [Full Text] [Related]
17. Chronic renal tubular effects in relation to urine cadmium levels. Mueller PW, Smith SJ, Steinberg KK, Thun MJ. Nephron; 1989 Jun; 52(1):45-54. PubMed ID: 2565539 [Abstract] [Full Text] [Related]